UPFRONT OVERALL SURVIVAL MODELLING IN COMPARISON TO REAL WORLD DATA: LENALIDOMIDE FOR THE TREATMENT OF MULTIPLE MYELOMA PATIENTS IN SOUTH KOREA

被引：0
|
作者：
Felix, J. [1 ]
Vandewalle, B. [1 ]
Almeida, J. [1 ]
Valeska, A. [1 ]
机构：
[1] Exigo Consultores, Lisbon, Portugal
来源：
VALUE IN HEALTH | 2014年 / 17卷 / 07期
关键词：
D O I：
10.1016/j.jval.2014.08.073
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PRM20
引用
收藏
页码：A729 / A729
页数：1
相关论文
共 50 条
  • [1] Subsequent Treatments, Responses and Survival in the Real World for Patients with Relapsed Multiple Myeloma Following Treatment with Lenalidomide
    Taube, Jessica B.
    Lecat, Catherine S. Y.
    Cheesman, Simon
    Wallis, Gabriel
    Kyriakou, Charalampia
    Lee, Lydia
    Mahmood, Shameem
    Papanikolaou, Xenofon
    Parrish, Christopher
    Rabin, Neil K.
    Sachchithananthan, Sajitha
    Sive, Jonathan
    Wechalekar, Ashutosh D.
    Yong, Kwee
    Cook, Gordon
    Popat, Rakesh
    BLOOD, 2019, 134
  • [2] Real World Treatment Outcomes of Multiple Myeloma in Korea
    Byun, Ja Min
    Yoon, Sung-Soo
    Shin, Dong-Yeop
    Koh, Youngil
    Kim, Inho
    Kim, Hyun Kyung
    Lee, Dong Soon
    Lee, Jung-Lim
    Kim, Byung Su
    BLOOD, 2016, 128 (22)
  • [3] Real-World Trends in Treatment Use, Healthcare Costs, and Overall Survival Among Patients with Multiple Myeloma
    Fonseca, Rafael
    Abouzaid, Safiya
    Bonafede, Machaon
    Cai, Qian
    Parikh, Kejal
    Cosler, Leon
    Richardson, Paul
    BLOOD, 2016, 128 (22)
  • [4] Real-world evidence for carfilzomib dosing intensity on overall survival and treatment progression in multiple myeloma patients
    Raje, Noopur
    Medhekar, Rohan
    Panjabi, Sumeet
    Hines, Dionne M.
    Wang, Xin
    Iskander, Karim
    Welliver, Tim
    Wade, Rolin L.
    Ailawadhi, Sikander
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2022, 28 (05) : 1130 - 1139
  • [5] Improvement in Overall Survival With Carfilzomib, Lenalidomide, and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma
    Siegel, David S.
    Dimopoulos, Meletios A.
    Ludwig, Heinz
    Facon, Thierry
    Goldschmidt, Hartmut
    Jakubowiak, Andrzej
    San-Miguel, Jesus
    Obreja, Mihaela
    Blaedel, Julie
    Stewart, A. Keith
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (08) : 728 - +
  • [6] Real World Treatment Patterns and Survival in Patients with Multiple Myeloma (MM) in Taiwan
    Hou, Hsin-An
    Tang, Chao-Hsiun
    Liu, Hung-Yi
    Qiu, Hong
    Siggins, Sarah
    Rothwell, Lee Anne
    Yang, Ya-Wen
    Pei, Sung-Nan
    Zhang, Yongjing
    Liu, Yanfang
    BLOOD, 2017, 130
  • [7] Lenalidomide data in multiple myeloma patients demonstrate impressive survival benefit
    不详
    ONCOLOGY-NEW YORK, 2007, 21 (09): : 1143 - 1143
  • [8] Real-world treatment patterns and outcomes in lenalidomide refractory multiple myeloma patients in Europe: a real-world survey
    Martinez-Lopez, Joaquin
    Mendes, Joao
    Luke, Emily
    Kluth, Caspian
    Salmon, Phoebe
    Bailey, Abigail
    Ribbands, Amanda
    Gay, Francesca
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S198 - S199
  • [9] Real World Use of Ixazomib With Lenalidomide and Dexamethasone for Patients With Relapsed Multiple Myeloma
    Lawson, Gabrielle
    Ziff, Monica
    De-Silva, Dunnya
    Cheesman, Simon
    Kyriakou, Charalampia
    Mehta, Atul
    Mahmood, Shameem
    Papanikolaou, Xenofon
    Rabin, Neil
    Sachchithanantham, Sajitha
    Sive, Jonathan
    Wechalekar, Ashutosh
    Yong, Kwee
    Popat, Rakesh
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E264 - E264
  • [10] REAL-WORLD EXPERIENCE OF LENALIDOMIDE/DEXAMETHASONE TREATMENT FOR REFRACTORY/RELAPSED MULTIPLE MYELOMA (RRMM) PATIENTS
    Tognazzi, L.
    Rivolti, E.
    Quaresima, M.
    Labbozzetta, S.
    Gamberi, B.
    Merli, F.
    HAEMATOLOGICA, 2017, 102 : 137 - 137
12345